论文部分内容阅读
目的探究胰岛素类似物诺和锐30治疗2型糖尿病的临床体会。方法将在我院于2015年1月至2016年1月接收治疗的40例2型糖尿病患者分为2组,各20例;对照组患者给予常规治疗,观察组患者在此基础上给予诺和锐30治疗,对比两组患者的治疗效果。结果在治疗有效率上,观察组95%,与对照组55%相比明显更高,两组数据差异有统计学意义(P<0.05);在空腹血糖及餐后2小时血糖指标上,观察组与对照组相比明显更低,两组数据差异有统计学意义(P<0.05)。结论在治疗2型糖尿病患者的过程中,给予诺和锐30治疗的效果良好,能有效改善患者临床症状。因此值得在临床治疗中推广使用。
Objective To investigate the clinical experience of insulin analog Nuo Rui 30 in treating type 2 diabetes mellitus. Methods Forty patients with type 2 diabetes treated in our hospital from January 2015 to January 2016 were divided into two groups of 20 patients each; Rui 30 treatment, the treatment effect of two groups of patients. Results The effective rate of treatment was 95% in the observation group, which was significantly higher than that in the control group (55%), with significant difference between the two groups (P <0.05). On the fasting blood glucose and 2-hour postprandial blood glucose The difference between the two groups was statistically significant (P <0.05). Conclusions In the treatment of type 2 diabetes patients, the effect of Novo-Rui-30 treatment is good, which can effectively improve the clinical symptoms of patients. It is worth to promote the use of clinical treatment.